Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are commonly prescribed to the growing number of cancer patients (more than two million in the UK alone) often to treat hypertension. However, increased fatal cancer in ARB users in a randomized...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cardwell, Chris R, Mc Menamin, Úna C, Hicks, Blánaid M, Hughes, Carmel, Cantwell, Marie M, Murray, Liam J
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926686/
https://ncbi.nlm.nih.gov/pubmed/24521426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-12-28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares